Spero Therapeutics Inc (NASDAQ:SPRO) traded at $2.74 at close of the session on Monday, June 02 and made an upward move of 9.60% on its previous day’s price.
Spero Therapeutics Inc has a market cap of $153.20 million and is expected to release its quarterly earnings report in July.
The median projection represents growth adding up to -100.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 5.9M, or -87.70% down from figures reported last year.
On the other hand, looking at the outlook for the SPRO stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 25% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Spero Therapeutics Inc (SPRO) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 172.95% off its SMA20 and 231.67% from its 50-day simple moving average. The RSI (14) is pointing at 87.60 while the volatility over the past week is 60.30% and jumps to 28.14% over the past one month. The beta value is 1.31, while the average true range (ATR) is currently pointing at 0.24.
